Hyperprolactinemia
Conditions
Interventions
Experimental group:BushenCuluan fang And Bromocriptine mesylate placebo
Control group:Bromocriptine mesylate tablets and BushenCuluan fang placebo
Sponsors
Xiyuan Hospital, Chinese Academy of Traditional Chinese medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1) Between 20 and 40 years old; (2) Meet the diagnostic criteria for infertility; (3) Meet the diagnostic criteria of hyperprolactinemia; (4) Meet the diagnostic criteria of TCM kidney deficiency and blood stasis syndrome; (5) Voluntarily sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) ovulation disorders or infertility caused by congenital physiological defects or malformations: (2) infertility caused by genetic factors; (3) Infertility caused by fallopian tube factors, or immune factors, or uterine fibroids, or myoadenosis, or endometriosis, or uterine dysplasia, confirmed by examination; (4) abnormal reproductive function of the spouse; (5) serious abnormalities of cardiovascular, liver, kidney or hematopoietic system; (6) Psychiatric diseases and other diseases that cause abnormal lactation; (7) Allergy to known investigational drug ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovulation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sex Hormone levels(FSH\ LH\ E2\P\T\PRL);Ovulatory B-ultrasound;Anti-mullerian hormone(AMH);Blood clotting (FIB, APTT, TT, PT);integral of TCM kidney deficiency and blood stasis syndrome;INHB;Early follicular stage B-ultrasound;Basal body temperature normalization rate; | — |
Countries
China
Contacts
Public ContactMaKun
Xiyuan Hospital, Chinese Academy of Traditional Chinese medicine
Outcome results
None listed